Analyst Ratings For NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
Today, Needham & Company LLC reiterated its Hold rating on NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD).
Some recent analyst ratings include
- 5/2/2018-Needham & Company LLC Reiterated Rating of Hold.
- 5/2/2018-Leerink Swann Reiterated Rating of Market Perform.
- 2/23/2018-Royal Bank of Canada Reiterated Rating of Buy.
- 2/12/2018-Mizuho Reiterated Rating of Buy .
Dividend information for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) pays an annual dividend of $2.28 with a yield of 3.39%.
Dividend History for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
- On 5/1/2018 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.57 3.14% with an ex dividend date of which will be payable on 6/28/2018.
- On 2/6/2018 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.57 3.02% with an ex dividend date of 3/15/2018 which will be payable on 3/29/2018.
- On 10/26/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 2.7% with an ex dividend date of 12/14/2017 which will be payable on 12/28/2017.
- On 7/26/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 2.78% with an ex dividend date of 9/14/2017 which will be payable on 9/28/2017.
- On 5/2/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 3.09% with an ex dividend date of 6/14/2017 which will be payable on 6/29/2017.
- On 2/7/2017 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.52 3.11% with an ex dividend date of 3/14/2017 which will be payable on 3/30/2017.
- On 11/1/2016 NASDAQ:GILD – Gilead Sciences announced a quarterly dividend of $0.47 2.59% with an ex dividend date of 12/13/2016 which will be payable on 12/29/2016.
Recent Insider Trading Activity For NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD) has insider ownership of 1.16% and institutional ownership of 78.43%.
- On 4/27/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $73.91 per share and the total transaction amounting to $431,117.03.
- On 4/20/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $73.74 per share and the total transaction amounting to $430,125.42.
- On 4/13/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $75.56 per share and the total transaction amounting to $440,741.48.
- On 4/6/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $74.47 per share and the total transaction amounting to $434,383.51.
- On 4/2/2018 John C Martin, Director, sold 50,000 with an average share price of $73.14 per share and the total transaction amounting to $3,657,000.00.
- On 3/23/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $75.02 per share and the total transaction amounting to $437,591.66.
- On 3/16/2018 John Francis Cogan, Director, sold 5,833 with an average share price of $80.09 per share and the total transaction amounting to $467,164.97.
Recent Trading Activity for NASDAQ:GILD – Gilead Sciences (NASDAQ:GILD)
Shares of NASDAQ:GILD – Gilead Sciences closed the previous trading session at 67.15 down -5.41 7.46% with 66.02050018310547 shares trading hands.